Reimbursement Challenges: Inability to secure and maintain adequate coverage and reimbursement from third-party payors for their genetic testing services, significantly impacting revenue and market adoption.

Regulatory Compliance: Failure to obtain or maintain necessary regulatory approvals and comply with complex and evolving regulations (e.g., CLIA, CAP, FDA) for their diagnostic tests and laboratory operations, potentially leading to operational disruptions or market withdrawal.

Intense Competition: Facing significant competition from larger diagnostic companies, academic institutions, and other specialized genetic testing providers, which could erode market share, depress pricing, and necessitate substantial R&D investment.